Generation of post-surgical minimal residual disease models to investigate metastasis in soft tissue sarcoma patient-derived orthotopic xenografts

STAR Protoc. 2024 Mar 15;5(1):102863. doi: 10.1016/j.xpro.2024.102863. Epub 2024 Feb 28.

Abstract

Despite optimal multimodal treatment including surgical resection, 50%-80% of high-grade soft tissue sarcoma (STS) patients metastasize. Here, we present a protocol for the generation and use of post-surgical minimal residual disease models to investigate metastatic relapse in STS patient-derived xenografts. We describe steps for orthotopic engraftment of high-grade STS patient-derived tumor tissue. We then detail procedures for primary tumor resection with broad, negative resection margins and follow-up until metastases using MRI. For complete details on the use and execution of this protocol, please refer to Fischer et al. (2023).1.

Keywords: Cancer; Clinical Protocol; Model Organisms.

MeSH terms

  • Heterografts
  • Humans
  • Magnetic Resonance Imaging
  • Neoplasm, Residual
  • Sarcoma* / diagnostic imaging
  • Sarcoma* / pathology
  • Sarcoma* / surgery
  • Soft Tissue Neoplasms* / diagnostic imaging
  • Soft Tissue Neoplasms* / pathology
  • Soft Tissue Neoplasms* / surgery